Event
Optical Imaging Workshop
Friday, September 28, 2018
8:30 a.m.-4:30 p.m.
The Hotel at the University of Maryland
cersi@umd.edu
You are cordially invited to attend a one-day workshop entitled “Translational Pathways for Optical Drugs and Devices for Cancer Imaging” hosted by the Food and Drug Administration (FDA) in collaboration with the National Cancer Institute (NCI) and the University of Maryland Centers of Excellence in Regulatory Science and Innovation (CERSI).
Agenda
Goals and Objectives
- To discuss regulatory expectations for the development of optical imaging drugs and devices and to identify efficient translational pathways forward.
- To hear perspectives from industry, academia, investigators and other stakeholders on how to enhance the clinical development on optical imaging drugs and devices.
Session Themes
- Drug and Device Development Requirements
- Clinical Trial Design Considerations
- Cross Labeling / Combination Products
- Panel and Open Forum Discussions
Attendance
Academia, investigators, device manufacturers, pharmaceutical companies, contract research organizations and government agencies are encouraged to attend.
When
September 28, 2018
8:30 am – 4:30 pm (On-site check-in begins at 7:30 am)
Where
The Hotel at the University of Maryland, 7777 Baltimore Avenue, College Park, MD
A hotel room block with a special room rate has been made available at The Hotel at the University of Maryland. To book your stay, please contact the Hotel at (301) 277-7777 and request a room under the "Optical Imaging Workshop" room block.
Registration
Registration for both on-site and remote participation is now open. Please note, if you are planning to access this event remotely, you must register for the event and separately submit your information to receive a customized Adobe Connect link ahead of the event.
